Table of Contents

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

 

(Mark One)

☒       QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: September 30, 2018

 

☐       TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________

 

Commission File Number: 000-17363

 

LIFEWAY FOODS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Illinois	36-3442829
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)

 

6431 West Oakton, Morton Grove, IL 60053

(Address of Principal Executive Offices, Zip Code)

 

(847) 967-1010

(Registrant’s Telephone Number, Including Area Code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data file required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one)

 

	Large accelerated filer  ☐	Accelerated filer  ☐
	Non-accelerated filer  ☐	Smaller reporting company  ☒
	Emerging growth company  ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ☐ No ☒

 

As of November 5, 2018, 15,837,695 shares of the registrant’s common stock, no par value, were outstanding.

 

 

 

 

 

TABLE OF CONTENTS

 

PART I – FINANCIAL INFORMATION
Item 1.	Financial Statements.	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	17
Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	22
Item 4.	Controls and Procedures.	22
PART II – OTHER INFORMATION
Item 1.	Legal Proceedings.	23
Item 1 A.	Risk Factors.	23
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	23
Item 3.	Defaults Upon Senior Securities.	23
Item 4.	Mine Safety Disclosure.	23
Item 5.	Other Information.	23
Item 6.	Exhibits.	23
	Signatures.	24

 

 

 

 

 

 

 

 

 

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS.

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Balance Sheets

September 30, 2018 and December 31, 2017

(In thousands)

 

		September 30, 2018 (Unaudited)				December 31, 2017
Current assets
Cash and cash equivalents		$	2,726			$	4,978
Investments, at fair value			500				–
Accounts receivable, net of allowance for doubtful accounts and discounts & allowances of $1,550 and $2,010 at September 30, 2018 and December 31, 2017 respectively			8,073				8,676
Inventories, net			6,837				7,697
Prepaid expenses and other current assets			1,298				983
Refundable income taxes			2,959				2,347
Total current assets			22,393				24,681
Property, plant and equipment, net			25,035				24,645
Intangible assets
Goodwill & indefinite-lived intangibles			14,068				14,068
Other intangible assets, net			485				975
Total intangible assets			14,553				15,043
Other assets			150				150
Total assets		$	62,131			$	64,519
Current liabilities
Current maturities of notes payable		$	–			$	3,166
Accounts payable			6,263				6,848
Accrued expenses			3,118				2,984
Accrued income taxes			82				203
Total current liabilities			9,463				13,201
Line of credit			5,990				–
Notes payable			–				3,113
Deferred income taxes, net			840				840
Other long-term liabilities			661				775
Total liabilities			16,954				17,929
Stockholders' equity
Preferred stock, no par value; 2,500 shares authorized; no shares issued or outstanding at September 30, 2018 and December 31, 2017, respectively			–				–
Common stock, no par value; 40,000 shares authorized; 17,274 shares issued; 15,838 and 16,008 outstanding at September 30, 2018 and December 31, 2017, respectively			6,509				6,509
Paid-in capital			2,211				2,244
Treasury stock, at cost			(12,918	)			(11,812	)
Retained earnings			49,375				49,649
Total stockholders' equity			45,177				46,590
Total liabilities and stockholders' equity		$	62,131			$	64,519

 

See accompanying notes to consolidated financial statements

 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Statements of Operations

For the three months and nine months ended September 30, 2018 and 2017

(Unaudited)

(In thousands, except per share data)

 

		Three Months Ended September 30,								Nine months Ended September 30,
		2018				2017				2018				2017
Net sales		$	24,480			$	28,786			$	80,318			$	92,636
Cost of goods sold			17,892				20,331				57,412				65,262
Depreciation expense			738				618				2,143				1,801
Total cost of goods sold			18,630				20,949				59,555				67,063
Gross profit			5,850				7,837				20,763				25,573
Selling expenses			3,136				4,010				10,537				11,648
General and administrative			3,150				3,145				9,851				10,743
Amortization expense			163				168				490				504
Total operating expenses			6,449				7,323				20,878				22,895
(Loss) income from operations			(599	)			514				(115	)			2,678
Other income (expense):
Interest expense			(82	)			(62	)			(220	)			(180	)
Gain (loss) on sale of property and equipment			28				(34	)			42				(39	)
Other income, net			3				–				11				–
Total other income (expense)			(51	)			(96	)			(167	)			(219	)
(Loss) income before provision for income taxes			(650	)			418				(282	)			2,459
(Benefit) provision for income taxes			(136	)			175				(8	)			1,056
Net (loss) income		$	(514	)		$	243			$	(274	)		$	1,403
(Loss) earnings per common share:
Basic		$	(0.03	)		$	0.02			$	(0.02	)		$	0.09
Diluted		$	(0.03	)		$	0.02			$	(0.02	)		$	0.09
Weighted average common shares:
Basic			15,872				16,093				15,886				16,123
Diluted			16,256				16,168				16,354				16,218

 

See accompanying notes to consolidated financial statements

 

 

 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Statements of Stockholders’ Equity 

For the Nine months Ended September 30, 2018 and 2017

(Unaudited)

(In thousands)

 

		Common Stock
		Issued								In treasury								Paid-In				Retained				Total
		Shares				$				Shares				$				Capital				Earnings				Equity
Balance, January 1, 2017			17,274			$	6,509				(1,120	)		$	(10,340	)		$	2,198			$	49,995			$	48,362
Treasury stock purchased			–				–				(117	)			(1,187	)			–				–				(1,187	)
Stock-based compensation			–				–				–				–				49				–				49
Net income			–				–				–				–				–				1,403				1,403
Balance, September 30, 2017			17,274			$	6,509				(1,237	)		$	(11,527	)		$	2,247			$	51,398			$	48,627
Balance, January 1, 2018			17,274			$	6,509				(1,266	)		$	(11,812	)		$	2,244			$	49,649			$	46,590
Issuance of common stock in connection with stock-based compensation			–				–				22				203				(71	)			–				132
Treasury stock purchased			–				–				(192	)			(1,309	)			–				–				(1,309	)
Stock-based compensation			–				–				–				–				38				–				38
Net loss			–				–				–				–				–				(274	)			(274	)
Balance, September 30, 2018			17,274			$	6,509				(1,436	)		$	(12,918	)		$	2,211			$	49,375			$	45,177

 

See accompanying notes to consolidated financial statements

 

 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Consolidated Statements of Cash Flows

For the Nine months Ended September 30, 2018 and 2017

(Unaudited)

(In thousands)

 

		2018				2017
Cash flows from operating activities:
Net (loss) income		$	(274	)		$	1,403
Adjustments to reconcile net income to operating cash flow:
Depreciation and amortization			2,633				2,305
Non-cash interest expense			9				–
Bad debt expense			50				–
Reserve for inventory obsolescence			580				320
Stock-based compensation			827				901
Deferred revenue			(72	)			–
(Gain) loss on sale of property and equipment			(42	)			39
(Increase) decrease in operating assets:
Accounts receivable			553				(814	)
Inventories			280				(328	)
Refundable income taxes			(612	)			(462	)
Prepaid expenses and other current assets			(291	)			(231	)
Increase (decrease) in operating liabilities:
Accounts payable			(586	)			1,384
Accrued expenses			(588	)			252
Accrued income taxes			(121	)			(580	)
Net cash provided by operating activities			2,346				4,189
Cash flows from investing activities:
Purchases of investments			(500	)			(25	)
Purchases of property and equipment			(2,581	)			(3,932	)
Proceeds from sale of property and equipment			90				37
Net cash used in investing activities			(2,991	)			(3,920	)
Cash flows from financing activities:
Borrowings under revolving credit facility			6,050				–
Payment of deferred financing costs			(69	)			–
Purchase of treasury stock			(1,309	)			(1,187	)
Repayment of notes payable			(6,279	)			(630	)
Net cash used in financing activities			(1,607	)			(1,817	)
Net decrease in cash and cash equivalents			(2,252	)			(1,548	)
Cash and cash equivalents at the beginning of the period			4,978				8,812
Cash and cash equivalents at the end of the period		$	2,726			$	7,264
Supplemental cash flow information:
Cash paid for income taxes, net of refunds		$	724			$	2,098
Cash paid for interest		$	189			$	180

 

See accompanying notes to consolidated financial statements

 

 

 

 

LIFEWAY FOODS, INC. AND SUBSIDIARIES

Notes to Consolidated Financial Statements

September 30, 2018 and December 31, 2017

(Unaudited)

(In thousands, except per share data)

 

Note 1 – Basis of Presentation

 

Basis of presentation

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (“U.S. GAAP”) for interim financial information, and do not include all of the information and disclosures required for complete, audited financial statements. In the opinion of management, all adjustments, consisting only of normal recurring adjustments, considered necessary for a fair presentation, have been included. For further information, refer to the consolidated financial statements and disclosures included in our Annual Report on Form 10-K as of and for the year ended December 31, 2017. Certain amounts in prior-year financial statements were reclassified to conform to the current-year presentation. The results for the period are not necessarily indicative of the results to be expected for other interim periods or the full year.

 

Principles of consolidation

 

Our consolidated financial statements include the accounts of Lifeway Foods, Inc. and all its wholly owned subsidiaries (collectively “Lifeway” or the “Company”). All significant intercompany accounts and transactions have been eliminated.

 

Note 2 – Significant Accounting Policies

 

Use of estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made in preparing the consolidated financial statements include the reserve for promotional allowances, the valuation of goodwill and intangible assets, stock-based and incentive compensation, and deferred income taxes.

 

Revenue Recognition

 

We sell food and beverage products across select product categories to customers predominantly within the United States (see Note 11, Segments, Products and Customers). We also sell bulk cream, a byproduct of our fluid milk manufacturing process. We recognize revenue when control over the products transfers to our customers, which generally occurs upon delivery to our customers or their common carriers. We account for product shipping and handling as fulfillment activities with revenues for these activities recorded within net revenue and costs recorded within cost of goods sold. Any taxes collected on behalf of government authorities are excluded from net revenues.

 

Revenues are recorded net of discounts and allowances to our customers and consumers. Known or expected pricing or revenue adjustments, such as trade discounts, allowances for non-saleable products, product returns, and coupon redemption, are estimated at the time of sale. We base these estimates of expected amounts principally on historical utilization and redemption rates. Estimates that affect revenue, such as trade incentives and coupon redemptions, are monitored and adjusted each period until the incentives realized or the coupons expire.

 

Key sales terms, such as pricing and quantities ordered, are established on a frequent basis such that most customer arrangements and related incentives have a one year or shorter duration. As such, we do not capitalize contract inception costs and we capitalize product fulfillment costs in accordance with U.S. GAAP and our inventory policies. We do not have any significant deferred revenue or unbilled receivables at the end of a period. We generally do not receive noncash consideration for the sale of goods nor do we grant payment financing terms greater than one year.

  

 

 

 

Deferred Financing Costs

 

We record deferred financing costs incurred in conjunction with its debt obligations. These costs are capitalized and amortized over the lives of the associated debt to interest expense using the effective interest method. Debt issuance costs associated with term debt and lines of credit are recorded as a direct deduction from the face amount of the debt. Total deferred financing costs, net of $9 and $0 of accumulated amortization, at September 30, 2018 and December 31, 2017 were $60 and $0, respectively.

 

Investments

 

All investment securities are classified as available-for-sale and are carried at fair value. The Company holds a Level 1 fair value investment in a short-term fixed income fund at September 30, 2018.

 

Advertising and promotional costs

 

Lifeway expenses advertising costs as incurred. For the nine months ended September 30, 2018 and 2017 total advertising expenses were $3,557 and $4,703 respectively. For the three months ended September 30, 2018 and 2017 total advertising expenses were $972 and $1,892 respectively.

 

Recently Adopted Accounting Pronouncements

 

In June 2018, the FASB issued ASU 2018-07, Improvements to Nonemployee Share-Based Payment Accounting. The new guidance is intended to simplify aspects of accounting for share-based payments to nonemployees by aligning it with the accounting for share-based payments to employees, with certain exceptions. The new guidance is effective for financial statements issued for fiscal years beginning after December 15, 2018, and interim periods within those years. Early adoption is permitted, but no earlier than an entity’s adoptions of Topic 606. We adopted this new standard in June 2018. The adoption of this amendment had no impact on the consolidated financial statements.

 

In May 2017, the Financial Accounting Standards Board ("FASB”) issued ASU No. 2017-09, Compensation – Stock Compensation (Topic 718): Scope of Modification Accounting. The new guidance provides clarity and reduces both diversity in practice and cost of complexity when accounting for a change to the terms of or conditions of a share-based payment award. The amendments in this update provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. This guidance was effective January 1, 2018. The adoption of this amendment had no impact on the consolidated financial statements.

 

In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows: Classification of Certain Cash Receipts and Cash Payments. The new guidance is intended to address the diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows, such as debt prepayment or debt extinguishment costs, contingent consideration payments made after an acquisition, proceeds from the settlement of insurance claims, and other topics. This guidance was effective January 1, 2018. The adoption of this amendment had no impact on the consolidated financial statements.

 

In January 2016, the FASB issued ASU No. 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities. The new guidance modifies how entities measure equity investments and present changes in the fair value of financial liabilities. Under the new guidance, entities will have to measure equity investments that do not result in consolidation and are not accounted under the equity method at fair value and recognize any changes in fair value in net income unless certain conditions exist. This guidance was effective January 1, 2018. The adoption of this amendment had no impact on the consolidated financial statements.

 

 

 

 

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”), which supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, including most industry-specific requirements. ASU 2014-09 establishes a five-step revenue recognition process in which an entity will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which an entity expects to be entitled in exchange for those goods or services. The standard allows for either “full retrospective” adoption, meaning the standard is applied to all of the periods presented, or “modified retrospective” adoption, meaning the standard is applied only to the most current period presented in the financial statements. ASU 2014-09 also requires enhanced disclosures regarding the nature, amount, timing and uncertainty of revenues and cash flows from contracts with customers. On August 12, 2015 the FASB approved a one year delay of the effective date to reporting periods beginning after December 15, 2017, while permitting companies to voluntarily adopt the new standard as of the original effective date. In December 2016, the FASB issued ASU No. 2016-20, Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers, which clarifies narrow aspects of ASC 606 or corrects unintended application of the guidance. The effective date and transition requirements for ASU 2016-20 are the same as the effective date and transition requirements for ASU 2014-09. Under the delayed effective date, this guidance was effective January 1, 2018. We adopted the new standard on January 1, 2018 on a modified retrospective basis. The adoption of this amendment had no impact on the consolidated financial statements. Refer to the Revenue Recognition section above and Note 11, Segment, Products, and Customers for additional information.

  

 

Recently Issued Accounting Pronouncements

 

In January 2017, the FASB issued ASU No. 2017-04, Intangibles - Goodwill and Other: Simplifying the Test for Goodwill Impairment. The new guidance simplifies the subsequent measurement of goodwill by removing the second step of the two-step impairment test. The amendment requires an entity to perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. The new guidance will be effective for annual periods or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. The amendment should be applied on a prospective basis. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The adoption of this amendment is not expected to have a material impact on the consolidated financial statements.

   

In February 2016, the FASB issued ASU No. 2016-02, Leases. The guidance requires lessees to recognize lease assets and lease liabilities in the balance sheet and disclose key information about leasing arrangements, such as information about variable lease payments and options to renew and terminate leases. The amended guidance will require both operating and finance leases to be recognized in the balance sheet. A lessee should recognize in the statement of financial position a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. The new guidance is effective for financial statements issued for fiscal years beginning after December 15, 2018, and interim periods within those years. Early adoption is permitted. The amendments in this ASU should be adopted using a modified retrospective transition approach, which requires application of the new guidance at the beginning of the earliest comparative period presented in the year of adoption. Management is currently evaluating the impact that the new guidance will have on the consolidated financial statements.

 

Note 3 – Inventories, net

 

Inventories consisted of the following:

 

		September 30, 2018				December 31, 2017
Ingredients		$	1,970			$	1,717
Packaging			2,064				2,453
Finished goods			2,803				3,527
Total inventories		$	6,837			$	7,697

 

 

 

 

Note 4 – Property, Plant and Equipment, net

 

Property, plant and equipment consisted of the following:

 

		September 30, 2018				December 31, 2017
Land		$	1,747			$	1,747
Buildings and improvements			17,446				17,260
Machinery and equipment			30,598				27,539
Vehicles			901				901
Office equipment			879				734
Construction in process			693				1,683
			52,264				49,864
Less accumulated depreciation			(27,229	)			(25,219	)
Total property, plant and equipment, net		$	25,035			$	24,645

  

 

Note 5 – Intangible Assets

 

Goodwill & indefinite-lived intangible assets consisted of the following:

 

		September 30, 2018				December 31, 2017
Goodwill		$	10,368			$	10,368
Brand names			3,700				3,700
Goodwill and indefinite-lived intangible assets		$	14,068			$	14,068

 

Other intangible assets, net consisted of the following:

 

		September 30, 2018				December 31, 2017
Recipes		$	44			$	44
Customer lists and other customer related intangibles			4,529				4,529
Customer relationship			985				985
Trade names			2,248				2,248
Formula			438				438
			8,244				8,244
Accumulated amortization			(7,759	)			(7,269	)
Other intangible assets, net		$	485			$	975

 

Note 6 – Accrued Expenses

 

Accrued expenses consisted of the following:

 

		September 30, 2018				December 31, 2017
Payroll and incentive compensation		$	2,271			$	2,208
Real estate taxes			401				371
Other			446				405
		$	3,118			$	2,984

 

 

 

 

Note 7 – Debt

 

Notes Payable

 

		September 30, 2018				December 31, 2017
Variable rate term loan due May 31, 2018. Principal and interest payable monthly with a balloon payment due at maturity. Paid in full.		$	–			$	2,832
Variable rate term loan due May 31, 2019. Principal and interest payable monthly with a balloon payment due at maturity. Paid in full.			–				3,447
Total term loans			–				6,279
Less current portion			–				(3,166	)
Total long-term portion		$	–			$	3,113

  

The variable rate term loans were subject to interest at the prime rate or at the LIBOR plus 2.5% and were collateralized by substantially all of Lifeway’s assets. The two term loans were refinanced and paid in full on May 7, 2018. See Line of Credit below.

 

Line of Credit

 

On May 7, 2018, Lifeway entered into an Amended and Restated Loan and Security Agreement (the “Revolving Credit Facility”) with its existing lender. The Revolving Credit Facility provides for a revolving line of credit up to a maximum of $10 million (the “Revolving Loan”) with an incremental facility not to exceed $5 million (the “Incremental Facility” and together with the Revolving Loan, the “Loans”). The proceeds of the Loans were used to pay off Lifeway’s existing debt with the lender under the Loan and Security Agreement, Revolving Note, and Term Note entered into on February 6, 2009, and for general working capital purposes. Upon closing, we retired all the then-outstanding term loans described above.

 

As of September 30, 2018, we have $5,990, net of $60 of unamortized deferred financing costs, outstanding under the New Revolving Credit Facility. We have approximately $3,950 available under the Borrowing Base for future borrowings as of September 30, 2018.

 

All outstanding amounts under the Loans bear interest, at Lifeway’s election, at either the lender Base Rate (the greater of either the Federal Funds Rate plus 0.5%, or the Prime Rate) or the LIBOR plus 2.50%, payable monthly in arrears. Lifeway is also required to pay a quarterly unused line fee and, in conjunction with the issuance of any letters of credit, a letter of credit fee. Lifeway’s interest rate on debt outstanding under our Credit Agreement for the period May 7, 2018 through September 30, 2018 ranged from 4.52% - 4.86%.

 

The commitment under the Revolving Credit Facility matures May 7, 2021. The new revolving line of credit is presented as a long-term debt obligation as of September 30, 2018. The Loans and all other amounts due and owed under the Revolving Credit Facility and related documents are secured by substantially all of our assets.

 

Amounts available for borrowing under the Loans equal the lesser of (i) the Borrowing Base (as defined below), or (ii) $10 million (plus the amount of any Incremental Facility requested by Lifeway and approved by lender), in each case, as the same is reduced by the aggregate principal amount outstanding under the Loans. “Borrowing Base” under the Revolving Credit Facility means, generally, an amount equal to our cash and cash equivalents plus our eligible accounts receivable and eligible inventory, less certain reserves, divided by 1.5.

 

The Revolving Credit Facility contains customary representations, warranties, and covenants on the part of Lifeway, including financial covenants requiring us to achieve a minimum EBITDA threshold for each of the fiscal quarters through December 31, 2018; maintain (a) a fixed charge coverage ratio of no less than 1.25 to 1.0, and (b) a Senior Debt to EBITDA ratio of not more than 3.00 to 1.0 at December 31, 2018 and for each of the succeeding fiscal quarters ending through the expiration date. The Revolving Credit Facility also provides for events of default, including failure to repay principal and interest when due and failure to perform or violation of the provisions or covenants of the agreement, as a result of which amounts due under the Revolving Credit Facility may be accelerated.

 

 

 

 

Note 8 – Commitments and contingencies

 

Lease obligations

 

We lease corporate office space, three retail stores for our Lifeway Kefir Shop subsidiary, and certain machinery and equipment, under operating leases. Total lease expense was $555 and $497 for the nine months ended September 30, 2018 and 2017, respectively. Total lease expense was $180 and $175 for the three months ended September 30, 2018 and 2017, respectively.

  

Litigation

 

Lifeway is engaged in various legal actions, claims, and proceedings arising in the normal course of business, including commercial disputes, product liabilities, intellectual property matters and employment-related matters resulting from our business activities.

 

We record accruals for outstanding legal matters when we believe it is probable that a loss will be incurred and the amount of such loss can be reasonably estimated. We evaluate, on a periodic basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and estimable, we do not establish an accrued liability. Currently, none of our accruals for outstanding legal matters are material individually or in the aggregate to our financial position and it is management’s opinion that the ultimate resolution of these outstanding legal matters will not have a material adverse effect on our business, financial condition, results of operations, or cash flows. However, if we ultimately are required to make payments in connection with an adverse outcome, it is possible that it could have a material adverse effect on our business, financial condition, results of operations or cash flows.

 

Lifeway’s contingencies are subject to substantial uncertainties, including for each such contingency the following, among other factors: (i) the procedural status of the case; (ii) whether the case has or may be certified as a class action suit; (iii) the outcome of preliminary motions; (iv) the impact of discovery; (v) whether there are significant factual issues to be determined or resolved; (vi) whether the proceedings involve a large number of parties and/or parties and claims in multiple jurisdictions or jurisdictions in which the relevant laws are complex or unclear; (vii) the extent of potential damages, which are often unspecified or indeterminate; and (viii) the status of settlement discussions, if any, and the settlement posture of the parties. Consequently, Lifeway cannot predict with any reasonable certainty the timing or outcome of such contingencies, and we are unable to estimate a possible loss or range of loss.

 

In a letter dated May 19, 2016, Lifeway received a request to voluntarily produce documents in connection with a confidential, informal inquiry by the Division of Enforcement of the SEC concerning Lifeway’s internal controls, disclosure controls procedures, and internal control over financial reporting for fiscal years 2013 through the date of the letter. Following the SEC’s issuance of a Wells Notice and discussions with the SEC staff about the SEC’s alleged claims, we reached an agreement in principle to resolve the inquiry on November 9, 2018. Under the terms of the proposed settlement, Lifeway would pay one hundred thousand dollars in a civil penalty and agree to cease and desist from committing or causing any violations and any future violations of Sections 13(a), 13(b)(2)(A) and 13(b)(2)(B) of the Exchange Act and Rules 13a-1, 13a-13, and 13a-15, thereunder. Lifeway will enter into the offer of settlement without admitting or denying the allegations therein and the settlement will resolve all allegations by the SEC against us. In accordance with U.S. GAAP, we made a corresponding accrual in our financial statements. The settlement remains subject to final approval by the SEC.

 

Note 9 – Income taxes

 

For each interim period, Lifeway estimates the effective tax rate (“ETR”) expected to be applicable for the full year and applies that rate to income before provision for income taxes for the period. Additionally, we record discrete income tax items such as enacted tax rate changes and completed tax audits in the period in which they occur.

 

The effective tax rate for the three months ended September 30, 2018 was 20.9% compared to 41.9% for the three months ended September 30, 2017. The effective tax rate for the nine months ended September 30, 2018 was 3.0% compared to 42.9% for the nine months ended September 30, 2017. On December 22, 2017, Congress enacted the Tax Cuts and Jobs Act of 2017. The Act contains several key tax provisions that affected us, including without limitation a reduction of the federal corporate income tax rate to 21% effective January 1, 2018, and the repeal of the domestic manufacturing deduction for 2018. In 2018, our effective income tax rate reflects the current federal statutory rate of 21%, while the rate for 2017 reflects the then-current federal statutory rate of 35%. The relative mix of pre-tax earnings (or losses), the underlying income tax rates applicable to various state and local taxing jurisdictions, and the impact of non-deductible items can also affect our periodic effective income tax rate.

  

 

 

 

Note 10 – Stock-based and Other Compensation

 

Stock Options

 

In December 2015, Lifeway shareholders approved the 2015 Omnibus Incentive Plan, which authorized the issuance of an aggregate of 3.5 million shares to satisfy awards of stock options, stock appreciation rights, unrestricted stock, restricted stock, restricted stock units, performance shares and performance units. At September 30, 2018, 3.469 million shares remain available under the Omnibus Incentive Plan. We have not established a pace for the frequency of awards under the Omnibus Incentive Plan, and may choose to suspend the issuance of new awards in the future and may grant additional awards at any time including issuing special grants of restricted stock, restricted stock units, and stock options to attract and retain new and existing executives.

 

The following table summarizes stock option activity during the nine months ended September 30, 2018:

 

		Options				Weighted average exercise price				Weighted average remaining contractual life				Aggregate intrinsic value
Outstanding at December 31, 2017			45			$	10.45
Granted			–			$	–
Exercised			–			$	–
Forfeited			(3)			$	11.10
Outstanding at September 30, 2018			42			$	10.40				7.50			$	–
Exercisable at September 30, 2018			36			$	10.42				7.50			$	–

  

For the nine months ended September 30, 2018 and 2017 total pre-tax stock-based compensation expense recognized in the consolidated statements of operations was $9 and $35, respectively. For the nine months ended September 30, 2018 and 2017 tax-related benefits of $2 and $14 were also recognized. For the three months ended September 30, 2018 and 2017 total pre-tax stock-based compensation expense recognized in the consolidated statements of operations was $2 and $6, respectively. For the three months ended September 30, 2018 and 2017 tax-related benefits of $0 and $3 were also recognized. As of September 30, 2018, the total remaining unearned compensation related to non-vested stock options was $4, which is expected to be amortized over the weighted-average remaining service period of 0.73 years.

 

Restricted Stock Units

 

Lifeway granted 20 Restricted Stock Units (“RSUs”) to certain independent directors in June 2018 and 6 RSU’s to employees during the quarter ended September 30, 2018. An RSU represents the right to receive one share of common stock in the future. RSUs have no exercise price.

 

The following table summarizes RSU activity during the nine months ended September 30, 2018:

 

		RSU’s
Outstanding at December 31, 2017			–
Granted			26
Shares issued upon vesting			–
Forfeited			–
Outstanding at September 30, 2018			26
Weighted average grant date fair value per share outstanding		$	5.63

  

 

 

 

We expense RSU’s over the service period. For the nine months ended September 30, 2018 and 2017 total pre-tax stock-based compensation expense recognized in the consolidated statements of operations was $29 and $14, respectively. For the nine months ended September 30, 2018 and 2017 tax-related benefits of $8 and $6 were also recognized. For the three months ended September 30, 2018 and 2017 total pre-tax stock-based compensation expense recognized in the consolidated statements of operations was $25 and $5, respectively. For the three months ended September 30, 2018 and 2017 tax-related benefits of $7 and $2 were also recognized. As of September 30, 2018, the total remaining unearned compensation related to non-vested RSU’s was $116, which is expected to be amortized over the weighted-average remaining service period of 1.30 years.

 

Incentive Compensation

 

In January 2017, Lifeway established an incentive-based compensation program for fiscal year 2017 (the “2017 Plan”) for certain senior executives and key employees (the “participants”). We established a similar plan for participants for fiscal year 2018 (the “2018” Plan). Under both the 2017 Plan and the 2018 Plan, incentive compensation is based on (a) Lifeway’s achievement of certain sales and adjusted EBITDA performance levels versus respective targets established by the Board for each fiscal year, and (b) for certain senior executives other than our CEO and COO, the achievement of individual performance objectives.

 

Under the 2017 Plan, collectively the participants had the opportunity to earn cash and equity-based incentive compensation in amounts ranging from $0 to $11,025 depending on Lifeway’s performance levels compared to the respective targets and the senior executive’s performance compared to their individual objectives. The equity portion of the incentive compensation is payable in restricted stock that vests one-third in each of the three years from the 2017 grant dates. For the nine months ended September 30, 2018, $551 was expensed under the 2017 Plan as stock-based compensation expense in the consolidated statements of operations. For the nine months ended September 30, 2017, $2,106 was expensed under the 2017 Plan, of which $1,254 was recorded as cash bonus expense and $852 was recorded as stock-based compensation expense in the consolidated statements of operations. For the three months ended September 30, 2018, $139 was expensed under the 2017 Plan as stock-based compensation expense in the consolidated statements of operations. For the three months ended September 30, 2017, $121 was expensed under the 2017 Plan, of which $6 was recorded as cash bonus expense and $115 was recorded as stock-based compensation expense in the consolidated statements of operations. As of September 30, 2018, the total remaining unearned compensation related to the 2017 Plan was $494, of which $139 is expected to be recognized through the balance of fiscal year 2018 subject to vesting; and $303 and $52 is expected to be recognized in 2019 and 2020, respectively, subject to vesting.

 

Under the 2018 Plan, collectively the participants have the opportunity to earn cash and equity-based incentive compensation in amounts ranging from $0 to $11,200 depending on Lifeway’s performance levels compared to the respective targets and the senior executive’s performance compared to their individual objectives. The equity portion of the incentive compensation is payable in restricted stock that vests one-third in each of the three years from the 2018 grant dates. For the nine months ended September 30, 2018, $303 was expensed under the 2018 Plan, of which $76 was recorded as cash bonus expense and $227 was recorded as stock-based compensation expense in the consolidated statements of operations. For the three months ended September 30, 2018, $157 was expensed under the 2018 Plan as stock-based compensation expense in the consolidated statements of operations.

 

Retirement Benefits

 

Lifeway has a defined contribution plan which is available to substantially all full-time employees. Under the terms of the plan, we match employee contributions under a prescribed formula. For the nine months ended September 30, 2018 and 2017 total contribution expense recognized in the consolidated statements of operations was $319 and $296, respectively. For the three months ended September 30, 2018 and 2017 total contribution expense recognized in the consolidated statements of operations was $90 and $59, respectively.

 

Note 11 – Segments, Products and Customers

 

Lifeway’s primary product is drinkable kefir, a cultured dairy product. Lifeway Kefir is a tart and tangy cultured milk smoothie that is high in protein, calcium and vitamin D. Thanks to our exclusive blend of kefir cultures, each cup of kefir contains 12 live and active cultures and 15 to 20 billion beneficial CFU (Colony Forming Units) at the time of manufacture.

  

 

 

 

We manufacture (directly or through co-packers) our products under our own brand, as well as under private labels on behalf of certain customers. Lifeway offers over 50 varieties of our kefir products including more than 20 flavors. In addition to our core drinkable kefir products, we offer Kefir Cups, a strained, cupped version of our kefir; and Organic Farmer Cheese Cups, a cupped version of our soft cheeses, both served in resealable 5 oz. containers with mini-spoons. We also offer Lifeway Elixir, a line of non-dairy, sparkling organic probiotic beverages, as well as probiotic supplements for adults and children. In late 2017, we also announced that we would begin offering Skyr, a strained cupped Icelandic yogurt, and Plantiful, a plant-based probiotic beverage made from organic and non-GMO pea protein with 10 vegan kefir cultures.

 

Our product categories are:

 

	•	Drinkable Kefir, sold in a variety of organic and non-organic sizes, flavors, and types, including low fat, non-fat, whole milk, protein, BioKefir (a 3.5 oz. kefir with additional probiotic cultures), and Kefir with Oats.
	•	Cheese, which includes European-style soft cheeses, and farmer cheese in resealable cups.
	•	Cream and other, consists primarily of cream, a byproduct of our fluid milk manufacturing process, and non-dairy products.
	•	ProBugs, a line of kefir products in drinkable, frozen, and freeze dried formats, designed for children.
	•	Cupped Kefir and Skyr, which include Cupped Kefir and Icelandic Skyr, a line of strained kefir and yogurt products in resealable cups.
	•	Frozen Kefir, available in both bars and pint-size containers.

 

Lifeway has determined that it has one reportable segment based on how our chief operating decision maker manages the business and in a manner consistent with the internal reporting provided to the chief operating decision maker. The chief operating decision maker, who is responsible for allocating resources and assessing our performance, has been identified collectively as the Chief Financial Officer, the Chief Operating Officer, the Chief Executive Officer, and Chairperson of the board of directors. Substantially all of our consolidated revenues relate to the sale of cultured dairy products that we produce using the same processes and materials and are sold to consumers through a common network of distributors and retailers in the United States.

 

Net sales of products by category were as follows for the nine months ended September 30:

 

		Nine months ended September 30,
		2018				%				2017				%
Drinkable Kefir other than ProBugs		$	61,255				76%			$	71,559				77%
Cheese			8,443				11%				8,527				9%
Cream and other			4,104				5%				5,053				5%
Cupped Kefir and Skyr			3,154				4%				2,379				3%
ProBugs Kefir			2,166				3%				3,700				4%
Frozen Kefir (a)			1,196				1%				1,418				2%
Net Sales		$	80,318				100%			$	92,636				100%

 

(a)	Includes Lifeway Kefir Shop sales

  

Net sales of products by category were as follows for the three months ended September 30:

 

		Three months ended September 30,
		2018				%				2017				%
Drinkable Kefir other than ProBugs		$	18,877				77%			$	22,154				77%
Cheese			2,656				11%				2,829				10%
Cream and other			1,406				6%				1,615				6%
Cupped Kefir and Skyr			699				3%				889				3%
ProBugs Kefir			471				2%				843				3%
Frozen Kefir (a)			371				1%				456				1%
Net Sales		$	24,480				100%			$	28,786				100%

 

(a)	Includes Lifeway Kefir Shop sales

 

 

 

 

Significant Customers – Sales are predominately to companies in the retail food industry, located within the United States. Two major customers accounted for approximately 22% of net sales for the nine months ended September 30, 2018 and 2017, and 20% and 21% of net sales for the three months ended September 30, 2018 and 2017, respectively.

 

Note 12 – Related party transactions

 

Lifeway obtains consulting services from the Chairperson of its board of directors. Fees earned by the Chairperson are included in general and administrative expenses in the accompanying consolidated statements of operations and were $750 during each of the nine months ended September 30, 2018 and 2017. Fees earned by the Chairperson are included in general and administrative expenses in the accompanying consolidated statements of operations and were $250 during each of the three months ended September 30, 2018 and 2017.

 

Lifeway is also a party to a royalty agreement with the Chairperson of its board of directors under which we pay the Chairperson a royalty based on the sale of certain Lifeway products, not to exceed $50 in any fiscal month. Royalties earned by the Chairperson are included in selling expenses in the accompanying consolidated statements of operations and were $445 and $450 during the nine months ended September 30, 2018 and 2017, respectively, and $145 and $150 during the three months ended September 30, 2018 and 2017, respectively

 

 

 

 

 

 

 

 

 

 

 

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) in this Form 10-Q is provided as a supplement to, and should be read in conjunction with, our audited consolidated financial statements, the accompanying notes, and the MD&A included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 (the “Form 10-K”). Unless otherwise specified, any description of “our”, “we”, and “us” in this MD&A refer to Lifeway Foods, Inc. and our subsidiaries.

 

Cautionary Statement Regarding Forward-Looking Statements

 

In addition to historical information, this quarterly report contains “forward-looking” statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of words such as "anticipate," "believe," "could," "estimate," "expect," "from time to time," "future," "intend," "plan," "likely," "may," "ongoing," "realize," "should," "will," and similar terms or terminology, or the negative of such terms or other comparable terminology. Examples of forward-looking statements include, among others, statements we make regarding:

 

	•	Expectations of the effect on our financial condition of claims, litigation, environmental costs, contingent liabilities and governmental and regulatory investigations and proceedings;
	•	Strategy for acquisitions, customer retention, growth, product development, market position, financial results and reserves; Estimates of the amounts of sales allowances and discounts to our customers and consumers;
	•	Our belief that we will maintain compliance with our loan agreements and have sufficient liquidity to fund our business operations;

 

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:

 

	•	The impact of investigative and legal proceedings;
	•	Developments and changes in laws and regulations, including regulation of the dairy or food industries through legislative action and revised rules and standards applied by the Food & Drug Administration (FDA);
	•	Economic and financial conditions, including volatility in interest and exchange rates, commodity and equity prices, and the value of our assets;
	•	Changes in the price of milk and other key materials and disruptions in supply chains for these materials;
	•	Strategic actions, including acquisitions and dispositions and our success in launching new products;
	•	The impact on our competitive position if we do not maintain compliance with our loan agreements and/or sufficient liquidity to fund our business operations;
	•	Such other factors as discussed throughout Part I, Item 1 “Business”; Part I, Item 1A “Risk Factors”; and Part II, Item 7 “Management's Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended December 31, 2017 and that are described from time to time in our filings with the SEC.

 

These factors are not necessarily all of the important factors that could cause actual results to differ materially from those expressed in any of our forward-looking statements. Other unknown or unpredictable factors could also have material adverse effects on future results. We intend these forward-looking statements to speak only at the date made. Except as otherwise required to be disclosed in periodic reports required to be filed by public companies with the SEC pursuant to the SEC's rules, we have no duty to update these statements, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

 

 

 

Three Months Ended September 30, 2018 Compared to Three Months Ended September 30, 2017

 

Results of Operations

(In thousands)

 

		September 30,								Favorable / (Unfavorable)
		2018				2017				$				%
Net sales		$	24,480			$	28,786			$	(4,306	)			(15.0%	)
Cost of goods sold		$	17,892			$	20,331			$	2,439
Depreciation expense			738				618				(120	)
Total cost of goods sold		$	18,630			$	20,949			$	2,319				11.1%
Gross profit		$	5,850			$	7,837			$	(1,987	)			(25.4%	)
Gross Profit % to net sales			23.9%				27.2%
Selling expenses		$	3,136			$	4,010			$	874				21.8%
Selling expenses % to net sales			12.8%				13.9%
General & administrative expenses		$	3,150			$	3,145			$	(5	)			(0.2%	)
General & administrative % to net sales			12.9%				10.9%
Amortization expense		$	163			$	168			$	5				3.0%
Total operating expenses		$	6,449			$	7,323			$	874				11.9%
Total operating expense % to net sales			26.3%				25.4%
(Loss) income from operations		$	(599	)		$	514			$	(1,113	)			(216.5%	)
(Loss) income from operations % to net sales			(2.4%	)			1.8%

 

Net Sales

 

Net sales finished at $24,480 for the three-month period ended September 30, 2018, a decrease of $4,306 or 15.0% versus prior year. The net sales softness continued to reflect the overall lower consumption in the dairy and cultured dairy product categories. Versus prior year, volume declines primarily resulted from volume / mix of 17.6% due to lower branded and ProBugs drinkable kefir sales, partially offset by new products. In addition, an increase in trade promotion and allowances of 0.6% resulted as targeted programming and product activity was executed. This was partially offset by pricing gains of 3.2% which commenced during second quarter 2018.

 

Gross Profit

 

Gross profit as a percentage of net sales was 23.9% during the three-month period ended September 30, 2018. Gross profit percentage was 27.2% in prior year. The decline versus prior year was primarily due to lower net sales, higher freight and fixed costs, partially offset by reduction in variable costs. Additionally, depreciation expense increased reflecting the continued investment in manufacturing improvements.

 

Selling Expenses

 

Selling expenses decreased by $874 or 21.8% to $3,136 during the three-month period ended September 30, 2018. The decrease versus prior year, primarily reflects a change in media spending to reduce programs with lower efficiency. The primary driver was the lapping of television media eliminated from third quarter 2018 that occurred in the previous year, and to a lesser extent lower broker commissions and marketing spending.

 

 

 

 

General and administrative expenses

 

General and administrative expenses were slightly higher for the three-month period ending September 30, 2018 finishing at $3,150, 0.2% above prior year. This reflects increased incentive compensation, partially offset by lower legal expenses.

 

Provision for Income Taxes

 

Benefit for income taxes was $136 during the three months ended September 30, 2018, compared to a provision for income taxes of $175 during the same period in 2017. Our effective tax rate (ETR) for the three months ended September 30, 2018 was 20.9% compared to an ETR of 41.9% in the same period last year. The lower effective tax rate reflects a high percentage of non-deductible tax expense against relatively low pre-tax book income/(loss).

 

On December 22, 2017, the Tax Cuts and Jobs Act (the “Act”) was signed into law. The Act significantly changed U.S. income tax law by, among other things, reducing the U.S. federal income tax rate from 35% to 21%, transitioning from a global tax system to a modified territorial tax system, eliminating the domestic manufacturing deduction, reducing the dividend received deduction, and limiting the tax deductions for interest expense and executive compensation.

 

An estimated provisional impact of the remeasurement of deferred income taxes was recorded in the provision (benefit) for income taxes for the year ended December 31, 2017. However, our review of the implications of the Act will be ongoing throughout 2018 as additional clarification and guidance are provided on how the IRS and state authorities will implement tax reform. We will also watch for additional guidance from the SEC or the FASB related to tax reform. Effective January 1, 2018, we currently estimate that the impact of the Act will lower our combined statutory federal income tax rate plus an estimate for state, local and foreign income taxes from approximately 39.5% to 27.7%. Among other effects, the Act’s lower federal statutory rate is partially offset by the adverse impact of the Act’s elimination of the domestic manufacturing deduction. In future periods, we expect the Act to favorably impact net earnings, diluted earnings per share, and cash flows, primarily due to the Act’s reduction of the federal corporate tax rate.

 

Income taxes are discussed in Note 9 in the Notes to the Consolidated Financial Statements.

 

Net income (loss)

 

We reported a net loss of $(514) or $(0.03) per basic and diluted common share for the three-month period ended September 30, 2018 compared to net income of $243 or $0.02 per basic and diluted common share in the same period in 2017.

  

Comparison of the nine-month period ended September 30, 2018 compared to the nine-month period ended September 30, 2017

 

Results of Operations

(In thousands) 

 

		September 30,								Favorable / (Unfavorable)
		2018				2017				$				%
Net sales		$	80,318			$	92,636			$	(12,318	)			(13.3%	)
Cost of goods sold		$	57,412			$	65,262			$	7,850
Depreciation expense			2,143				1,801				(342	)
Total cost of goods sold		$	59,555			$	67,063			$	7,508				11.2%
Gross profit		$	20,763			$	25,573			$	(4,810	)			(18.8%	)
Gross Profit % to net sales			25.9%				27.6%
Selling expenses		$	10,537			$	11,648			$	1,111				9.5%
Selling expenses % to net sales			13.1%				12.6%
General & administrative expenses		$	9,851			$	10,743			$	892				8.3%
General & administrative % to net sales			12.3%				11.6%
Amortization expense		$	490			$	504			$	14				2.8%
Total operating expenses		$	20,878			$	22,895			$	2,017				8.8%
Total operating expense % to net sales			26.0%				24.7%
(Loss) income from operations		$	(115	)		$	2,678			$	(2,793	)			(104.3%	)
(Loss) income from operations % to net sales			(0.1%	)			2.9%

 

 

 

 

 

Net Sales

 

Net sales were $80,318 for the nine-month period ended September 30, 2018, a decrease of $12,318 or 13.3%. The decline was primarily due to volume / mix of 15.7%, partially offset by lower spend in trade promotion and allowances of 1.0%, partially offset by pricing gains of 1.4%. The decline in volume / mix was primarily driven by volume softness in our branded and ProBugs drinkable kefir, partially offset by the incremental volume of new item introductions. The volume decline reflects lower consumption of our products that is consistent with the overall volume decline in dairy and cultured dairy product categories.

 

Pricing primarily includes the favorable impact of a second quarter 2018 price increase to recover higher input costs. This increase was partially offset by the lapping of a price reduction driven by the shift in delivery method for select customers in the first quarter 2017. The favorable promotional activity reflects lower trade spending, partially offset by the increased redemptions on our 2018 coupon program.

 

Gross Profit

 

Gross profit as a percentage of net sales decreased to 25.9% during the nine-month period ended September 30, 2018 from 27.6% during the same period in 2017. The lower gross profit percentage primarily reflects category sales softness, product mix, fixed costs and incremental coupon activity. This was partially offset by an increase in pricing and lower trade spending.

 

Selling Expenses

 

Selling expenses decreased by $1,111 or 9.5% to $10,537 during the nine-month period ended September 30, 2018 from $11,648 during the same period in 2017. The decreased selling expenses primarily reflect the reduction in lower efficiency media spending and lower broker commissions and other marketing spending.

 

General and administrative expenses

 

General and administrative expenses decreased $892 or 8.3% to $9,851 during the nine-month period ended September 30, 2018 from $10,743 during the same period in 2017. The decrease is primarily a result of lower incentive compensation.

 

Provision for Income Tax

 

Benefit for income taxes was $8 during the nine-months ended September 30, 2018, compared to a provision for income taxes of $1,056 during the same period in 2017. Our effective tax rate (ETR) for the nine-months ended September 30, 2018 was 3.0% compared to an ETR of 42.9% in the same period last year. The low effective tax rate reflects a high percentage of non-deductible tax expense against low pre-tax book income results.

 

On December 22, 2017, the Tax Cuts and Jobs Act was signed into law. The Act significantly changed U.S. income tax law by, among other things, reducing the U.S. federal income tax rate from 35% to 21%, transitioning from a global tax system to a modified territorial tax system, eliminating the domestic manufacturing deduction, reducing the dividend received deduction, and limiting the tax deductions for interest expense and executive compensation.

 

An estimated provisional impact of the remeasurement of deferred income taxes was recorded in the provision (benefit) for income taxes for the year ended December 31, 2017. However, our review of the implications of the Act will be ongoing throughout 2018 as additional clarification and guidance are provided on how the IRS and state authorities will implement tax reform. We will also watch for additional guidance from the SEC or the FASB related to tax reform. Effective January 1, 2018, we currently estimate that the impact of the Act will lower our combined statutory federal income tax rate plus an estimate for state, local and foreign income taxes from approximately 39.5% to 27.7%. Among other effects, the Act’s lower federal statutory rate is partially offset by the adverse impact of the Act’s elimination of the domestic manufacturing deduction. In future periods, we expect the Act to favorably impact net earnings, diluted earnings per share, and cash flows, primarily due to the Act’s reduction of the federal corporate tax rate.

 

Income taxes are discussed in Note 9 in the Notes to the Consolidated Financial Statements.

 

 

 

 

Net income (loss)

 

We reported a net loss of $(274) or $(0.02) per basic and diluted common share for the nine-month period ended September 30, 2018 compared to net income of $1,403 or $0.09 per basic and diluted common share in the same period in 2017.

 

Liquidity and Capital Resources

 

We expect to meet our foreseeable liquidity and capital resource requirements through anticipated cash flows from operations; our revolving credit facility; and cash and cash equivalents. The success of our business and financing strategies will continue to provide us with the financial flexibility to take advantage of various opportunities as they arise.

 

Sources and Uses of Cash

 

Lifeway had a net decrease in cash and cash equivalents of $1,752 during the nine-month period ended September 30, 2018 compared to a net decrease in cash and cash equivalents of $1,548 in the same period in 2017. The drivers of the year over year change are as follows:

  

Net cash provided by operating activities was $2,346 during the nine-month period ended September 30, 2018 compared to net cash provided by operating activities of $4,189 in the same period in 2017. The decline in cash provided by operating activities reflects lower net income and timing of accrued expenses.

 

Net cash used in investing activities was $2,991 during the nine-month period ended September 30, 2018 compared to net cash used in investing activities of $3,920 in the same period in 2017. The lower level of net cash used in investing activities in the 2018 period reflects lower capital spending. Capital spending was $2,581 during the period ended September 30, 2018 compared to $3,932 in 2017. Our capital spending is focused in three core areas, growth, cost reduction, and facility improvements. Growth capital spending supports new product innovation and enhancements. Cost reduction spending supports manufacturing efficiency, safety and productivity.

 

Net cash used in financing activities was $1,607 during the nine months ended September 30, 2018 compared to net cash used in financing activities of $1,817 in the same period in 2017. On November 1, 2017, Lifeway’s Board approved an increase in the aggregate amount under our previously announced 2015 stock repurchase program (the “2017 Repurchase Plan Amendment”), by adding to (i.e., exclusive of the shares previously authorized under the 2015 stock repurchase program) the authorization the lesser of $5,185 or 625 shares. We repurchased approximately 192 shares of common stock at a cost of $1,309 during the nine-month period ended September 30, 2018 under the 2017 Repurchase Plan Amendment. We may execute transactions from time to time in the open market or by private negotiation, in accordance with all applicable securities laws and regulations. We intend to hold repurchased shares in treasury for general corporate purposes, including issuances under our 2015 Omnibus Incentive Plan. Treasury shares are accounted for using the cost method.

 

Revolving credit facility. On May 7, 2018 Lifeway entered into an Amended and Restated Loan and Security Agreement (the “Revolving Credit Facility”) with its existing lender. The Revolving Credit Facility provides for a revolving line of credit up to a maximum of $10 million (the “Revolving Loan”) with an incremental facility not to exceed $5 million (the “Incremental Facility” and together with the Revolving Loan, the “Loans”).

 

The Revolving Credit Facility contains financial covenants requiring us to achieve a minimum EBITDA threshold for each of the fiscal quarters during the year ended December 31, 2018 and maintain (a) a fixed charge coverage ratio of no less than 1.25 to 1.0, and (b) a senior debt to EBTIDA ratio of not more than 3.0 to 1.0 at December 31, 2018 and for each of the succeeding fiscal quarters ending through the expiration date. We were in compliance with the applicable covenants as of September 30, 2018.

 

We used the revolving credit facility to retire all the then-outstanding term loans described in Note 7 to the consolidated financial statements. The revolving credit facility provides us advantages over our prior debt facilities, including that it does not require scheduled principal payments, gives us access to unused credit capacity, and does not require costly annual amendments or extensions. Additionally, we have no debt maturities until May 2021.

 

 

 

 

We have been able to deploy capital resources to take advantage of targeted growth opportunities, including the development of our cupped kefir and cheese products, and to improve our manufacturing platform’s capacity and capabilities. We believe we have ample access to additional capital, as evidenced by our revolving credit facility transaction in May 2018, and we may issue debt or equity securities from time to time when we determine that market conditions and the opportunity to utilize the proceeds from the issuance of such securities are favorable. Such opportunities could include refinancing existing indebtedness, funding capital expenditures, extending our debt maturities in a favorable interest rate environment, or taking advantage of acquisition opportunities that generate favorable returns.

  

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

There have been no material changes to our market risk during the third quarter of 2018. For information regarding our exposure to certain market risk, see Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk”, in the 2017 Form 10-K.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

(a)	Evaluation of Disclosure Controls and Procedures

 

Our evaluation of the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act was performed under the supervision and with the participation of our senior management, including our Chief Executive Officer and Chief Financial Officer. The purpose of disclosure controls and procedures is to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosures. Based upon our most recent controls evaluation, our CEO and CFO have concluded that our Disclosure Controls were effective as of September 30, 2018.

 

(b)	Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting during the third quarter of 2018 that were identified in connection with management’s evaluation required by paragraph (d) of Rules 13a-15 and 15d-15 under the Exchange Act that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 

 

 

 

 

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

From time to time we are engaged in litigation matters arising in the ordinary course of business. While the results of litigation and claims cannot be predicted with certainty, Lifeway believes that no such matter is reasonably likely to have a material adverse effect on our financial position or results of operations.

 

ITEM 1A. RISK FACTORS.

 

There have been no material changes to the Risk Factors disclosed in Part I, Item 1A of the 2017 Form 10-K.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

Issuer Purchases of Equity Securities

 

None.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURE.

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

None.

 

ITEM 6. EXHIBITS.

 

No.	Description		Form		Period Ending		Exhibit		Filing Date
10.1	Employment Agreement dated July 20, 2018 with Neha J. Clark.		8-K				10.1		8/3/18
31.1	Rule 13a-14(a)/15d-14(a) Certification of Julie Smolyansky		Filed Herewith
31.2	Rule 13a-14(a)/15d-14(a) Certification of Neha Clark		Filed Herewith
32.1	Section 1350 Certification of Julie Smolyansky		Filed Herewith
32.2	Section 1350 Certification of Neha Clark		Filed Herewith
99.1	Press release dated November 14, 2018 reporting Lifeway’s financial results for the nine months ended September 30, 2018.		Furnished Herewith
101	Interactive Data Files		Filed Herewith

 

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	LIFEWAY FOODS, INC.
Date: November 14, 2018	By:	/s/ Julie Smolyansky
		Julie Smolyansky
		Chief Executive Officer, President, and Director
		(Principal Executive Officer)
Date: November 14, 2018	By:	/s/ Neha Clark
		Neha Clark
		Chief Financial Officer
		(Principal Financial Officer)